Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 298 entries
View as:

Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation

Phase: N/A Priority: Normal
NCT ID: NCT01519219 Org: User:
Start: 11/24/04 End: 02/19/20 Due: 02/19/21

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00189137 Org: User:
Start: 08/31/04 End: 10/31/15 Due: 10/31/16

Computer-Based Tailored or Standard Information for Colorectal Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT00955188 Org: User:
Start: 08/31/04 End: 05/31/08 Due: 05/31/09

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05866302 Org: User:
Start: 05/30/23 End: 05/31/28 Due: 05/31/29

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01457885 Org: User:
Start: 11/30/11 End: 06/14/16 Due: 06/14/17

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02989714 Org: User:
Start: 03/16/17 End: 06/23/20 Due: 06/23/21

A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00148122 Org: User:
Start: 11/30/02 End: 07/31/10 Due: 07/31/11

Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03161665 Org: User:
Start: 01/14/16 End: 01/06/17 Due: 01/06/18

Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype

Phase: N/A Priority: Normal
NCT ID: NCT05691400 Org: User:
Start: 03/31/24 End: 03/31/27 Due: 03/31/28

Breast Cancer Resiliency Through Exercise Program (B-REP)

Phase: N/A Priority: Normal
NCT ID: NCT06100263 Org: User:
Start: 05/28/24 End: 12/31/26 Due: 12/31/27

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02805179 Org: User:
Start: 09/22/16 End: 11/18/20 Due: 11/18/21

Cardiac Rehabilitation to Improve Breast Cancer Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05867667 Org: User:
Start: 03/19/24 End: 08/13/24 Due: 08/13/25

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03570619 Org: User:
Start: 12/14/18 End: 03/26/24 Due: 03/26/25

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02145403 Org: User:
Start: 10/31/14 End: 10/16/20 Due: 10/16/21

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Phase: N/A Priority: Normal
NCT ID: NCT00143884 Org: User:
Start: 03/31/00 End: - Due: -

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04194554 Org: User:
Start: 11/06/20 End: 05/31/27 Due: 05/31/28

A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)

Phase: N/A Priority: Normal
NCT ID: NCT01519232 Org: User:
Start: 08/31/08 End: 05/31/14 Due: 05/31/15

Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT03515356 Org: User:
Start: 06/13/18 End: 06/24/19 Due: 06/24/20

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01700010 Org: User:
Start: 11/30/12 End: 01/31/19 Due: 01/31/20

Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging

Phase: N/A Priority: Normal
NCT ID: NCT04852471 Org: User:
Start: 01/05/22 End: 05/02/23 Due: 05/02/24

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02059213 Org: User:
Start: 06/30/14 End: 06/04/19 Due: 06/04/20

A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02006407 Org: User:
Start: 06/30/13 End: 12/31/15 Due: 12/31/16

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT04503668 Org: User:
Start: 12/28/20 End: 03/11/24 Due: 03/11/25

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03168152 Org: User:
Start: 05/11/17 End: 04/01/22 Due: 04/01/23

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Phase: N/A Priority: Normal
NCT ID: NCT03352427 Org: User:
Start: 12/06/17 End: 05/15/19 Due: 05/15/20